RUTW241226P2340000
- 77.06
- 0.000.00%
Russell 2000 Index Newsroom
Douglas Emmett Analyst Ratings
CareTrust REIT Analyst Ratings
Dow Surges Over 300 Points; US Initial Jobless Claims Decline
Top 10 Tech Stocks per SA Quant Grades as the Nasdaq Rises to Start 2025
Neumora Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up -80.6%
Neumora Therapeutics Analyst Ratings
4 Stocks to Watch on Wednesday: TSLA, FUL and More
Funko Analyst Ratings
BWS Financial Initiates Coverage On Movado Group With Buy Rating, Announces Price Target of $31.5
Movado Group Analyst Ratings
A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts
8 Analysts Have This To Say About Dave
89bio Analyst Ratings
Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
IShares Trust Russell 2000 Index Fund: Pivot Points
This L3Harris Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
LifeMD, Inc. 8.875% CUM PFD A Goes Ex Dividend Tomorrow
Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.
Dave Analyst Ratings
Today's Pre-Market Movers and Top Ratings | NVDA, UBER, SYNA and More